• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Claudin 18.2-a FAST-moving target in gastric cancer?

作者信息

Athauda A, Chau I

机构信息

Department of Medicine, Royal Marsden Hospital, London and Surrey, UK.

Department of Medicine, Royal Marsden Hospital, London and Surrey, UK.

出版信息

Ann Oncol. 2021 May;32(5):584-586. doi: 10.1016/j.annonc.2021.02.021. Epub 2021 Mar 4.

DOI:10.1016/j.annonc.2021.02.021
PMID:33677015
Abstract
摘要

相似文献

1
Claudin 18.2-a FAST-moving target in gastric cancer?紧密连接蛋白18.2——胃癌中一个快速变化的靶点？
Ann Oncol. 2021 May;32(5):584-586. doi: 10.1016/j.annonc.2021.02.021. Epub 2021 Mar 4.
2
Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.靶向胃癌及其他实体瘤中成纤维细胞生长因子受体2亚型b和紧密连接蛋白18亚型2剪接变体的单克隆抗体。
Clin Transl Med. 2024 Jun;14(6):e1736. doi: 10.1002/ctm2.1736.
3
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.FAST：一项关于zolbetuximab（IMAB362）联合EOX 对比 EOX 一线治疗晚期 CLDN18.2 阳性胃和胃食管腺癌的随机 II 期研究。
Ann Oncol. 2021 May;32(5):609-619. doi: 10.1016/j.annonc.2021.02.005. Epub 2021 Feb 19.
4
Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype.胃癌中的紧密连接蛋白1、3、4和5，紧密连接蛋白表达缺失与弥漫型亚型相关。
Virchows Arch. 2006 Jan;448(1):52-8. doi: 10.1007/s00428-005-0011-6. Epub 2005 Oct 12.
5
Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.Claudin-18 作为一种标志物，用于确定转移性腺癌的胃和胰胆部位为主要部位。
Am J Surg Pathol. 2020 Dec;44(12):1643-1648. doi: 10.1097/PAS.0000000000001583.
6
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.抗claudin 18.2抗体作为晚期胃癌的新型靶向治疗方法。
J Hematol Oncol. 2017 May 12;10(1):105. doi: 10.1186/s13045-017-0473-4.
7
Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.紧密连接蛋白在食管腺癌及其前驱病变中的过表达。
Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):24-30. doi: 10.1097/01.pai.0000151933.04800.1c.
8
[Claudin-3 expression in gastric cancer].[胃癌中Claudin-3的表达]
Arkh Patol. 2020;82(2):5-11. doi: 10.17116/patol2020820215.
9
Claudin-6 enhances cell invasiveness through claudin-1 in AGS human adenocarcinoma gastric cancer cells.紧密连接蛋白6通过紧密连接蛋白1增强AGS人胃腺癌细胞的侵袭能力。
Exp Cell Res. 2017 Jan 1;350(1):226-235. doi: 10.1016/j.yexcr.2016.11.025. Epub 2016 Dec 1.
10
TLR2 activation induced by H. pylori LPS promotes the differential expression of claudin-4, -6, -7 and -9 via either STAT3 and ERK1/2 in AGS cells.幽门螺杆菌脂多糖诱导的Toll样受体2（TLR2）激活通过信号转导和转录激活因子3（STAT3）及细胞外信号调节激酶1/2（ERK1/2）促进AGS细胞中紧密连接蛋白4、6、7和9的差异表达。
Immunobiology. 2018 Jan;223(1):38-48. doi: 10.1016/j.imbio.2017.10.016. Epub 2017 Oct 6.

引用本文的文献

1
Gastric Cancer Signaling Pathways and Therapeutic Applications.胃癌信号通路及治疗应用。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241271935. doi: 10.1177/15330338241271935.
2
Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer.基于生物标志物的晚期胃癌靶向治疗及免疫检查点抑制剂的研究进展与展望
Front Oncol. 2024 Jun 14;14:1382183. doi: 10.3389/fonc.2024.1382183. eCollection 2024.
3
High Expression of CLDN 18.2 is Associated with Poor Disease-Free Survival of HER-2 Positive Gastric Cancer.
CLDN 18.2的高表达与HER-2阳性胃癌的无病生存期差相关。
Int J Gen Med. 2024 Apr 29;17:1695-1705. doi: 10.2147/IJGM.S453883. eCollection 2024.
4
Construction of a Human Immune Library from Gallbladder Cancer Patients for the Single-Chain Fragment Variable () Antibody Selection against Claudin 18.2 via Phage Display.构建胆囊癌患者的人免疫文库，用于通过噬菌体展示筛选针对Claudin 18.2的单链可变片段（scFv）抗体。
Antibodies (Basel). 2024 Mar 12;13(1):20. doi: 10.3390/antib13010020.
5
Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study. Claudin 18.2 在消化道神经内分泌肿瘤中的表达：一项临床病理研究。
J Endocrinol Invest. 2024 May;47(5):1251-1260. doi: 10.1007/s40618-023-02245-7. Epub 2023 Dec 7.
6
Optimizing the Continuum of Care in Gastric Cancer.优化胃癌的连续护理
Onco Targets Ther. 2023 Nov 23;16:995-1012. doi: 10.2147/OTT.S365505. eCollection 2023.
7
Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging.用于癌症治疗的单克隆抗体的治疗靶点：现状与新进展
Biomedicines. 2023 Jul 24;11(7):2086. doi: 10.3390/biomedicines11072086.
8
Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies.胃食管腺癌中的抗Claudin治疗：主流与新兴策略
J Clin Med. 2023 Apr 19;12(8):2973. doi: 10.3390/jcm12082973.
9
Claudin and pancreatic cancer.紧密连接蛋白与胰腺癌
Front Oncol. 2023 Mar 7;13:1136227. doi: 10.3389/fonc.2023.1136227. eCollection 2023.
10
Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer.与传统胃癌相比，甲胎蛋白产生型胃癌中claudin-18.2的表达降低。
J Gastrointest Oncol. 2022 Jun;13(3):1035-1045. doi: 10.21037/jgo-22-462.